These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20199856)

  • 21. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis.
    Caminati A; Bianchi A; Cassandro R; Mirenda MR; Harari S
    Respir Med; 2009 Jan; 103(1):117-23. PubMed ID: 18786822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Faner R; Rojas M; Macnee W; Agustí A
    Am J Respir Crit Care Med; 2012 Aug; 186(4):306-13. PubMed ID: 22582162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
    Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
    Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
    Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit.
    Mallick S
    Respir Med; 2008 Oct; 102(10):1355-9. PubMed ID: 18635345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery disease in Saudi Arabia.
    Al-Nozha MM; Arafah MR; Al-Mazrou YY; Al-Maatouq MA; Khan NB; Khalil MZ; Al-Khadra AH; Al-Marzouki K; Abdullah MA; Al-Harthi SS; Al-Shahid MS; Nouh MS; Al-Mobeireek A
    Saudi Med J; 2004 Sep; 25(9):1165-71. PubMed ID: 15448760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study.
    García-Sancho Figueroa MC; Carrillo G; Pérez-Padilla R; Fernández-Plata MR; Buendía-Roldán I; Vargas MH; Selman M
    Respir Med; 2010 Feb; 104(2):305-9. PubMed ID: 19782552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis.
    Judge EP; Fabre A; Adamali HI; Egan JJ
    Eur Respir J; 2012 Jul; 40(1):93-100. PubMed ID: 22135282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
    Raghu G; Amatto VC; Behr J; Stowasser S
    Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The prevalence of angiographically significant coronary artery disease in patients with isolated secundum atrial septal defect].
    Cay S; Oztürk S; Cağirci G; Yetim M; Büyükterzi Z
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):451-5. PubMed ID: 19155658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans.
    Kokolis S; Marmur JD; Clark LT; Kassotis J; Kokolis R; Cavusoglu E; Lapin R; Breitbart S; Lazar JM
    J Invasive Cardiol; 2006 Jul; 18(7):304-7. PubMed ID: 16816434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis.
    Mermigkis C; Stagaki E; Amfilochiou A; Polychronopoulos V; Korkonikitas P; Mermigkis D; Bregou M; Kouris N; Bouros D
    Med Princ Pract; 2009; 18(1):10-5. PubMed ID: 19060484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Step towards understanding coronary artery disease: a complication in idiopathic pulmonary fibrosis.
    Sinha R; Nanavaty D; Azhar A; Devarakonda P; Singh S; Garikipati R; Sanghvi A; Manoharan S; Parhar G; Zaman K; Ayala-Rodriguez C; Vasudevan V; Reddy S; Gerolemou L
    BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38508700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of patients with coronary artery disease managed on an outpatient basis in the population of Poland. Results of the multicentre RECENT trial.
    Banasiak W; Pociupany R; Wilkins A; Ponikowski P
    Kardiol Pol; 2007 Feb; 65(2):132-40; discussion 141-2. PubMed ID: 17366357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of chronic obstructive pulmonary disease and tobacco use in veterans at Boise Veterans Affairs Medical Center.
    Thompson WH; St-Hilaire S
    Respir Care; 2010 May; 55(5):555-60. PubMed ID: 20420725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arterial hypertension in patients with chronic obstructive pulmonary disease in combination with coronary artery disease].
    Klester EB; Shoĭkhet IaN
    Ter Arkh; 2008; 80(9):13-7. PubMed ID: 19555029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between pulmonary fibrosis and coronary artery disease.
    Kizer JR; Zisman DA; Blumenthal NP; Kotloff RM; Kimmel SE; Strieter RM; Arcasoy SM; Ferrari VA; Hansen-Flaschen J
    Arch Intern Med; 2004 Mar; 164(5):551-6. PubMed ID: 15006833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients.
    Poredos P; Jug B
    Angiology; 2007; 58(3):309-15. PubMed ID: 17626985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases.
    King C; Nathan SD
    Curr Opin Pulm Med; 2013 Sep; 19(5):466-73. PubMed ID: 23912191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.